ST. PAUL, Minn. - (Business Wire) Synovis Life Technologies, Inc. (Nasdaq: SYNO), announced today that it has hired Patrick L. Horan to fill the key role of vice president of sales for the Surgical Group. Richard W. Kramp, president and chief executive officer, said, “We are extremely happy to have Patrick join our team and we feel fortunate to have attracted a professional of his caliber. Pat came on board just in time to attend the first National Symposium on Veritas Collagen Matrix held in conjunction with the American Society of Plastic Surgeons Meeting in Seattle, Washington. This was an ideal way to get introduced to our premier tissue product as he heard four surgeon thought leaders present their experience with Veritas, and he participated in the resulting discussion among the 40 to 50 surgeon attendees. Shortly thereafter, he attended Surgical’s national sales meeting and personally met each member of the team. “Patrick will lead Surgical’s region managers and territory sales representatives as they continue to expand our presence in the soft tissue regeneration and reconstruction market in the new fiscal year. He comes to us from Medtronic where, over the past 10 years, he held positions of increasing responsibility in corporate sales, sales operations development and group purchasing contract negotiations; and where he gained a breadth of experience in multiple business variables affecting the healthcare environment. This background and experience will be valuable to Synovis as our products become a more significant portion of hospital purchases,” Kramp continued.
Horan has a bachelor’s degree in business administration from the University of Missouri and certificates of continuing education in Advanced Negotiations and Negotiator Facilitation from Harvard Law School, Healthcare Finance and Accounting from the Wharton School of Business, Pricing Strategies and Tactics from the Kellogg School of Business Management of Northwestern University and several other certifications in leadership and management.
“Patrick is also very active in the healthcare industry, recently holding positions as vicechairman of the Healthcare Industry Supply Chain Institute, a director of the Global Healthcare Exchange and director of the Health Industry Group Purchasing Association. He is a strong addition to our growing company and brings a new level of expertise and sophistication to our sales effort,” Kramp added.
About Synovis Life Technologies
Synovis Life Technologies, Inc., based in St. Paul, Minn., is a diversified medical device company that develops, manufactures and markets medical devices for the surgical treatment of disease. The company’s products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools – all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs. For additional information on Synovis Life Technologies and its products, visit the company’s Web site at www.synovislife.com.
Forward-looking statements contained in this press release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The statements can be identified by words such as “should”, “could”, “may”, “will”, “expect”, “believe”, “anticipate”, “estimate”, “continue”, or other similar expressions. Certain important factors that could cause results to differ materially from those anticipated by the forward-looking statements made herein include the timing of product introductions, the ability of our expanding direct sales force to grow revenues, outcomes of clinical and marketing trials as well as regulatory submissions, the number of certain surgical procedures performed, the ability to identify, acquire and successfully integrate suitable acquisition candidates such as Pegasus Biologics, the cost and outcome of intellectual property litigation, any operational or financial impact of the current global economic downturn, current market conditions affecting its investments and any claims for indemnification related to the sale of the interventional business, as well as the other factors found in the company’s reports to the Securities and Exchange Commission, including on Annual Report on Form 10-K, as amended by Form 10-K/A (Amendment No. 1) for the year ended October 31, 2008.
Padilla Speer Beardsley Inc.
Nancy A. Johnson
612-455-1745
or
Marian Briggs
612-455-1742
or
Synovis Life Technologies, Inc.
Richard W. Kramp, President and CEO
651-796-7300
or
Brett Reynolds, CFO
651-796-7300
